About EmVenio Research
EmVenio Research is a company based in Durham (United States) founded in 2020 was acquired by PCM Trials in February 2024. EmVenio Research has raised $13.67 million across 2 funding rounds from investors including PCM Trials. EmVenio Research offers products and services including Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement. EmVenio Research operates in a competitive market with competitors including Landmark Health, Jet Health, Bright Health Group, Wellbox and WINFertility, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.67 M (USD)
in 2 rounds
-
Latest Funding Round
$9.17 M (USD), Series A
Dec 06, 2022
- Investors
-
Employee Count
Not available
-
Acquired by
PCM Trials
(Feb 23, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EmVenio Research
EmVenio Research offers a comprehensive portfolio of products and services, including Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement.
Network of sites for conducting clinical trials in communities.
Flexible visits that bring clinical trials directly to participants.
Strategies for engaging and retaining diverse patient groups.
Community-based model for recruiting underrepresented populations.
People of EmVenio Research
Unlock access to complete
Funding Insights of EmVenio Research
EmVenio Research has successfully raised a total of $13.67M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.17 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EmVenio Research
EmVenio Research has secured backing from 1 investor. Prominent investors backing the company include PCM Trials.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers clinical trial networks and mobile services for sponsors worldwide.
|
Locked | Locked | Locked |
Investor details for EmVenio Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EmVenio Research
Investment portfolio details for EmVenio Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EmVenio Research
Detailed financials for EmVenio Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emvenio Research Comparisons
Peer comparison for EmVenio Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EmVenio Research
EmVenio Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Landmark Health, Jet Health, Bright Health Group, Wellbox and WINFertility, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A medical group that delivers house calls and team-based interdisciplinary care to chronically ill population.
|
|
| Locked | Locked | Locked |
House call medical services are provided to patients at home.
|
|
| Locked | Locked | Locked |
Personalized care services are delivered in the healthcare sector.
|
|
| Locked | Locked | Locked |
Patient engagement and chronic care management services are provided.
|
|
| Locked | Locked | Locked |
Provider of family benefit solutions to employers, health plans, and individual patients
|
|
| Locked | Locked | Locked |
Patient engagement services are provided for healthcare providers.
|
Detailed competitors of EmVenio Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emvenio Research
Complete news archive for EmVenio Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EmVenio Research
EmVenio Research was founded in 2020 and raised its 1st funding round 2 years after it was founded.
EmVenio Research is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Keith Henthorne is the current CEO of EmVenio Research.
EmVenio Research is a funded company, having raised a total of $13.67M across 2 funding rounds to date.
EmVenio Research was founded in 2020 and is headquartered in Durham, United States. Operations focus on the healthcare sector, where clinical trials support is offered alongside patient engagement initiatives and general research services. These activities are conducted to facilitate medical studies and participant involvement. Leadership is provided by CEO Keith Henthorne, with services targeted at research organizations and healthcare providers in the region.
EmVenio Research's top competitors include Landmark Health, Melodi Health and Bright Health Group.
EmVenio Research offers Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement.
EmVenio Research has 1 investor. Key investors include PCM Trials.